Saturday, December 4

20 companies directed to halt production in Bangladesh



High Court has directed 20 pharmaceutical companies to stop production after their medicines were found to be substandard. The court also issued a rule seeking explanation as to why the licenses of these companies should not be cancelled.

A High Court bench consisting of Judges Dastagir Hossain and AKM Shahidul Huq passed the order today. Earlier, a parliamentary probe committee formed by the Health Ministry investigated 84 pharmaceutical companies in 2014.

The probe committee report suggested cancellation of licenses of 20 companies, which include, Exim Pharmaceuticals, Globe Laboratories and Evert Pharma. Cancellation of antibiotic medicine manufacturing license of 14 companies was also proposed by the committee.